Who is sponsoring NCT05269758?

NCT05269758 is sponsored by Hvidovre University Hospital.

What drugs are being tested in NCT05269758?

Interventions in NCT05269758: activity-based resistance training of ingestive skills (ACT-ING-program).

What condition does NCT05269758 study?

NCT05269758 studies Sarcopenia, Dysphagia.

Is NCT05269758 still recruiting?

NCT05269758 is currently completed. Last updated 2 March 2023.

Last reviewed 2023-03-02 · How we verify

NCT05269758

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Feasibility and Impact of Resistance Training for Sarcopenic Dysphagia

Completed Last updated 2 March 2023

What this trial tests

trial testing activity-based resistance training of ingestive skills (ACT-ING-program) in Sarcopenia in 11 participants. Completed in 28 February 2023.

Timeline

1 December 2020

Primary endpoint
6 January 2023

28 February 2023

Quick facts

Lead sponsor	Hvidovre University Hospital
Status	Completed
Study type	OBSERVATIONAL
Enrollment	11
Start date	1 December 2020
Primary completion	6 January 2023
Estimated completion	28 February 2023
Sites	1 location across Denmark

Drugs / interventions tested

activity-based resistance training of ingestive skills (ACT-ING-program)

Conditions studied

Sarcopenia — all drugs for Sarcopenia →
Dysphagia — all drugs for Dysphagia →

Sponsor

Hvidovre University Hospital

Who can join

65 and older, any sex, with Sarcopenia or Dysphagia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of the study is to test and optimize the feasibility of an activity-based resistance training program for patients with sarcopenic dysphagia. The study is a feasibility study designed as a multiple-case study with quantitative and qualitative data sources related to a number of feasibility outcomes and clinical outcomes during and after the intervention. Participants are 15 patients\> 65 years of age are referred for dysphagia assessment by an Occupational Therapist (patients may be admitted to several different wards (endocrinology, pulmonary medicine, infectious medicine, gastrology). The intervention is offered during hospitalization and after discharge for a maximum of 12 weeks.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Early Feasibility of an Activity-Based Intervention for Improving Ingestive Functions in Older Adults with Oropharyngeal Dysphagia.
Hansen T, Laursen LB, Hansen MS. · · 2023 · cited 4× · PMID 37102970 · DOI 10.3390/geriatrics8020044

Verify or expand the search:

Other recruiting trials for Sarcopenia

Currently open trials in the same condition.

NCT07500376 — Multimodal Nutritional and Sarcopenia Assessment for Risk Stratification in Lung Cancer Surgery · recruiting
NCT07456956 — HIIT vs MCIT for Stroke-Related Sarcopenia in Ischemic Stroke · NA · recruiting
NCT07398495 — Multimodal Training Effects in Middle-Aged and Older Adults With Diabetic Sarcopenia · NA · recruiting
NCT07494916 — Effects of Functional Task Training on Muscle Health and Function in Older Adults With Sarcopenia · NA · active not recruiting
NCT07426159 — AI-Guided Sarcopenia Risk Assessment and Detection · NA · active not recruiting

Other Hvidovre University Hospital trials

Trials by the same sponsor.

NCT07561164 — Feasibility of a Co-designed Mobility Intervention After Hip Fracture Surgery · NA · not yet recruiting
NCT06909240 — Progressive Gait Training After First-time Deep Venous Thrombosis: Clinical Effectiveness and Involved Mecanisms (The DV · NA · recruiting
NCT07054216 — Probiotic for Infants · NA · recruiting
NCT07029334 — Effectiveness Evaluation of Social Prescribing · recruiting
NCT06789484 — Characterization of the Gastrointestinal Microbiota in Newborn Infants · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05269758 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Hvidovre University Hospital
Last refreshed: 2 March 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05269758.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing